science97b Science 1997. 277:1652-1655

Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis.

Ruggero De Maria*, Luisa Lenti#, Florence Malisan*, Federica d'Agostino#, Barbara Tomassini*, Ann Zeuner*, Maria Rita Rippo* and Roberto Testi*

*Department of Experimental Medicine and Biochemical Sciences, University of Rome "Tor Vergata," 00133 Rome. #Department of Experimental Medicine and Pathology, University of Rome "La Sapienza", 00161 Rome.

Corresponding author: Roberto Testi

Gangliosides participate in development and tissue differentiation. Cross-linking of the apoptosis-inducing CD95 protein (also called Fas or APO-1) in lymphoid and myeloid tumor cells triggered GD3 ganglioside synthesis and transient accumulation. CD95-induced GD3 accumulation depended on integral receptor "death domains" and on activation of a family of cysteine proteases called caspases. Cell-permeating ceramides, which are potent inducers of apoptosis, also triggered GD3 synthesis. GD3 disrupted mitochondrial transmembrane potential (DeltaPsi m), and induced apoptosis, in a caspase-independent fashion. Transient overexpression of the GD3 synthase gene directly triggered apoptosis. Pharmacological inhibition of GD3 synthesis and exposure to GD3 synthase antisense oligodeoxynucleotides prevented CD95-induced apoptosis. Thus, GD3 ganglioside mediates the propagation of CD95-generated apoptotic signals in hematopoietic cells.